The embodiment described herein are related nanoemulsions comprising botulinum toxins. In one embodiment, the nanoemulsions are prepared by high pressure microfluidization and comprise a particle size distribution exclusively between 10 and 300 nm. The nanoemulsions contemplated by the present inven
The embodiment described herein are related nanoemulsions comprising botulinum toxins. In one embodiment, the nanoemulsions are prepared by high pressure microfluidization and comprise a particle size distribution exclusively between 10 and 300 nm. The nanoemulsions contemplated by the present invention are useful for the cosmetic and medical treatment of muscular contracture states. For example, botulinum toxin may relax facial muscles such that skin wrinkles become smoother and less noticeable. Further, the present invention contemplates a cosmetic formulation that may be self-administered, for example, in the privacy of one's home and without medical supervision.
대표청구항▼
1. A topical composition comprising a nanoemulsion comprising oily particles dispersed within an aqueous dispersion medium, wherein the majority of the oily particles have diameters between approximately 10 and approximately 300 nanometers; wherein the nanoemulsion comprises at least one botulinum t
1. A topical composition comprising a nanoemulsion comprising oily particles dispersed within an aqueous dispersion medium, wherein the majority of the oily particles have diameters between approximately 10 and approximately 300 nanometers; wherein the nanoemulsion comprises at least one botulinum toxin, a surfactant, and an oil, wherein the oil and surfactant are present in a ratio between 0.5 and 2.0;wherein the composition is formulated so that the botulinum toxin can penetrate human skin without use of an abrasive or disrupting agent, wherein the abrasive or disrupting agent is selected from the group consisting of: chemical permeation enhancers, mechanical permeation enhancers, electrical permeation enhancers and magnetic permeation enhancers; and,wherein the topical composition is formulated as a cream, a lotion, a gel, an ointment, a spray, a powder, an emollient, or combination thereof, for transdermal administration. 2. The topical composition of claim 1, wherein the percent of oil ranges from 1% to 30% of the nanoemulsion. 3. The topical composition of claim 1, wherein the aqueous dispersion medium is selected from the group consisting of water, saline solution, phosphate buffered saline, short chain alcohols, 5% dextrose, Ringer's solution, lactated Ringer's injection, lactated Ringer's plus 5% dextrose injection, acylated Ringer's injection, and combinations thereof. 4. The topical composition of claim 1, wherein the surfactant is selected from the group consisting of phosphoglycerides; phosphatidylcholines; dipalmitoyl phosphatidylcholine (DPPC); dioleylphosphatidyl ethanolamine (DOPE); dioleyloxypropyltriethylammonium (DOTMA); dioleoylphosphatidylcholine; cholesterol; cholesterol ester; diacylglycerol; diacylglycerolsuccinate; diphosphatidyl glycerol (DPPG); hexanedecanol; fatty alcohols such as polyethylene glycol (PEG); polyoxyethylene-9-lauryl ether; a surface active fatty acid, such as palmitic acid or oleic acid; fatty acids; fatty acid monoglycerides; fatty acid diglycerides; fatty acid amides; sorbitan trioleate glycocholate; sorbitan monolaurate; polysorbate 20; polysorbate 61; polysorbate 66; polysorbate; polysorbate 85; polyoxyethylene monostearate; surfactin; a poloxomer; a sorbitan fatty acid ester such as sorbitan trioleate; lecithin; lysolecithin; phosphatidylserine; phosphatidylinositol; sphingomyelin; phosphatidylethanolamine (cephalin); cardiolipin; phosphatidic acid; cerebrosides; dicetylphosphate; dipalmitoylphosphatidylglycerol; stearylamine; dodecylamine; hexadecyl-amine; acetyl palmitate; glycerol ricinoleate; hexadecyl sterate; isopropyl myristate; tyloxapol; poly(ethylene glycol)5000-phosphatidylethanolamine; poly(ethylene glycol)400-monostearate; phospholipids; synthetic and/or natural detergents having high surfactant properties; deoxycholates; cyclodextrins; chaotropic salts; ion pairing agents; and combinations thereof. 5. The topical composition of claim 1, wherein the botulinum toxin is selected from the group consisting of type A, type B, type C1, type C2, type D, type F, and type G. 6. The topical composition of claim 1, wherein the botulinum toxin is type A botulinum toxin. 7. The topical composition of claim 1, wherein the botulinum toxin is a botulinum toxin complex. 8. The topical composition of claim 7, wherein the botulinum toxin complex comprises a non-toxin hemagglutinin protein and a non-toxic non-hemagglutinin protein. 9. The topical composition of claim 1, wherein the botulinum toxin is incorporated within an albumin matrix. 10. The topical composition of claim 9, wherein the albumin is human albumin. 11. The topical composition of claim 1, wherein the botulinum toxin is a purified botulinum toxin protein or fragment thereof that retains at least one biological activity. 12. The topical composition of claim 1, wherein the botulinum toxin is isolated, or substantially isolated, from other proteins. 13. The topical composition of claim 1, wherein the botulinum toxin is isolated, or substantially isolated, from non-toxin proteins. 14. The topical composition of claim 1, wherein the botulinum toxin is isolated from Clostridium botulinum. 15. The topical composition of claim 1, wherein the botulinum toxin is chemically synthesized. 16. The topical composition of claim 1, wherein the botulinum toxin is produced recombinantly. 17. The topical composition of claim 1, wherein the botulinum toxin is: i) encapsulated within the particles;ii) adsorbed on the surface of the particles; and/oriii) associated with the particle interface. 18. The topical composition of claim 1, wherein the nanoemulsion can penetrate the top layer of skin. 19. The topical composition of claim 18, wherein the top layer of the skin is the surface of the stratum corneum. 20. The topical composition of claim 18, wherein the top layer of the skin includes dermal pores. 21. The topical composition of claim 18, wherein the top layer of the skin includes dermal glands.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (59)
Cook Edward J. (South Hamilton MA) Lagace Arthur P. (Newtonville MA), Apparatus for forming emulsions.
Steel Ian,GBX ; Kitchen Guy Stanley Hawksworth,GBX ; Flockhart Ian Ronald,GBX, Aqueous compositions comprising a lipid and a lanolin-derived surfactant, and their use.
Behan John M. (Shermel ; Ball Lane Kennington ; Ashford ; Kent GB3) Ness Jeremy N. (22 River Court Chartham ; Canterbury ; Kent GB3) Traas Petrus C. (Amersfoortsestraatweg 132 1411 HK Naarden NLX) Vi, Aqueous perfume oil microemulsions.
Garcia Sanz, Nuria; Van Den Nest, Wim; Carreno Serraima, Cristina; Ferrer Montiel, Antonio; Cebrian Puche, Juan; Alminana Domenech, Nuria, Cosmetic or pharmaceutical peptides containing uncoded amino acids and their use in the treatment and/or care of the skin, mucous membranes, or scalp.
Binder William J. (1640 Amalfi Dr. Pacific Palisades CA 90272), Method for treatment of skin lesions associated with cutaneous cell-proliferative disorders.
Cervantes Frederic,FRX ; Cazin Benedicte,FRX ; Simonnet Jean-Thierry,FRX, Nanoemulsion based on nonionic amphiphilic lipids and aminated silicones and uses.
Simonnet Jean-Thierry,FRX ; Sonneville Odile,FRX ; Legret Sylvie,FRX, Nanoemulsion based on phosphoric acid fatty acid esters and its uses in the cosmetics, dermatological, pharmaceutical, and/or ophthalmological fields.
Cox Donald Joseph ; Kearney Donald Raymond ; Kirksey ; Jr. Sanford Theodore ; Taylor Matthew Joel, Oil-in-water dispersions of .beta.-carotene and other carotenoids stable against oxidation prepared from water-dispersible beadlets having high concentrations of carotenoid.
Van Den Nest, Wim; Almiñana Domenech, Nuria; Cebrián Puche, Juan; Carreño Serraïma, Cristina, Peptides useful in the treatment and/or care of skin, mucous membranes, scalp and/or hair and their use in cosmetic or pharmaceutical compositions.
Vallet Mas Jose Alberto,ESX ; Galan Valdivia Francisco Javier,ESX ; Perdiguer Nuria Carreras,ESX, Process for coating droplets or nanometric particles.
Bosch H. William (Bryn Mawr PA) Marcera Donna M. (Collegeville PA) Mueller Ronald L. (Downingtown PA) Swanson Jon R. (Macungie PA) Mishra Dinesh S. (Harleysville PA), Process for preparing therapeutic compositions containing nanoparticles.
Weder Hans G. (Saumerstrasse 68 CH-8800 Thalwil CHX) Mtsch Matthias (Zurich CHX), Process for the production of a nanoemulsion of oil particles in an aqueous phase.
Ribier ; deceased Alain,FRX ITX by Roger Ribier ; legal representative ; Simonnet Jean-Thierry,FRX ; Legret Sylvie,FRX, Transparent nanoemulsion less than 100 NM based on fluid non-ionic amphiphilic lipids and use in cosmetic or in dermoph.
Miettinen Tatu (Helsinki FIX) Vanhanen Hannu (Helsinki FIX) Wester Ingmar (Raisio FIX), Use of a stanol fatty acid ester for reducing serum cholesterol level.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.